The effects of symbiotic supplement on complications of type 2 diabetes

Phase 3

Recruiting

Conditions: Type 2 diabetes.
Type 2 diabetes mellitus without complications

Registration Number: IRCT20190103042220N1

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Willingness to cooperate and complete informed informed consent form • Patients aged 30-70 years • Body mass index = 35 kg / m2 • haveType 2 diabetes • No history of alcohol or alcohol less than 10 grams Per day in women and less than 20 grams per day in men • no pregnancy and lactation • no thyroid gland disorders • no kidney and inflammatory disease • failure to follow weight loss regimens 6 months before the start of the study • no use Slimming drugs (Orlites, Slim Lists) and fat burners, fiber powder • Non-use of glucocorticoids and non-steroidal anti-inflammatory drugs • no use of insulin

Exclusion Criteria

•show complications associated with supplementation• No regular use of supplement• Consume less than 80% of supplements in three months

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in fasting blood sugare. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.;Triglyceird level. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.;Low-density lipoprotein. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.;High-density lipoprotein. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.;Serum insulin level. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.;High-sensitive C-reactive protein. Timepoint: At the baseline of intervention and at the end of study. Method of measurement: Enzymatic methods using kit.

Secondary Outcome Measures